✦ LIBER ✦

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

✍ Scribed by Amerigo Boiardi; Mirco Bartolomei; Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Ida Milanesi; Andrea Botturi; Paola Rocca; Lisa Bodei; Giovanni Broggi; Giovanni Paganelli

Book ID: 106480084
Publisher: Springer US
Year: 2005
Tongue: English
Weight: 263 KB
Volume: 72
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-004-1497-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

503 Phase I radioimmunotherapy (RIT) stu

503 Phase I radioimmunotherapy (RIT) study of 90Y-CC49 monoclonal antibody (MAb) therapy in patients with advanced non-small cell lung cancer (NSCLC)

✍ Robert, F.; Meredith, R.F.; Khazaeli, M.B.; Russell, C.; Grizzle, W.; Newsome, J 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Cilengitide in patients with recurrent g

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

✍ Mark R. Gilbert; John Kuhn; Kathleen R. Lamborn; Frank Lieberman; Patrick Y. Wen 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 202 KB

The city of hope experience with novel t

The city of hope experience with novel transplant regimens that incorporate standard and escalated dose 90YTTRIUM ibritumomab tiuxetan (90Y-Zevalin®) radioimmunotherapy (RIT) for autologous stem cell transplantation (ASCT) in patients with B-cell non-Hodgkin’s lymphoma (NHL): targeted intensification without increased toxicity and elimination of total body irradiation (TBI)

✍ A. Nademanee; H. Fung; A. Molina; A. Krishnan; R. Rodriguez; L. Popplewell; R.T. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 56 KB